Sleeping without pillows may help lower high internal eye pressure, build-up of which causes optic nerve damage and ...

Sleeping without pillows may help lower high internal eye pressure, the build-up of which causes optic nerve damage and ...

A collaborative research team has developed the world's first AI-based optical diagnostic platform that enables rapid and ...

Ken Carson from Bangor was first diagnosed with optic neuritis in 2001 following a routine eye examination and subsequent ...

FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.

This roundup highlights recent FDA updates related to drug approvals and devices used by optometric eye care professionals.

Oculis Holding AG recently reported that its neuroprotective candidate Privosegtor received U.S. FDA Breakthrough Therapy designation for optic neuritis, supported by positive Phase 2 ACUITY data and ...

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential market of $7B+ in the U.S. aloneMultiple milestones ...

Eye disease specialist Oculis SA is laying plans to branch out into multiple sclerosis (MS) after the phase II trials of its acute optic neuritis (AON) drug, privosegtor, showed it reduced levels of ...

Oculis (OCS) stock jumps as the FDA grants Breakthrough Therapy designation for its eye disease drug Privosegtor targeted at optic neuritis. Read more here.